← Eichor
Study identifier: NCT04342026 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Role of the Environment and Endocrine Disruptors in Child Cryptorchidism

Condition: Cryptorchidism  ·  Sponsor: University Hospital, Montpellier

PhaseN/A
Planned participants1452
Who can joinMale, 1 Month to 18 Years
Healthy volunteersNo

About this study

Cryptorchidism is the most frequent congenital defect of the male newborn. It requires surgery in childhood, increases the risk of fertility disorders and cancer. As a major public health objective, it's the subject of numerous recommendations. Its frequency is increasing in some countries faster than a single genetic cause could not explain it. It may occurs in a geographic cluster. The cause of cryptorchidism involves genetic, hormonal and environmental factors. Animal studies suggest that endocrine disruptors interfere with fetal testicular migration. The aim of the study is to find out if some environmental exposition may be associated with cryptorchidism.

This description comes directly from the study's public registry record.

Talk to the study team

Nicolas KALFA, MD  ·  00334 67 33 87 84  ·  n-kalfa@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University hospital of MontpellierMontpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04342026